Researchers identify medulloblastoma molecular groups using noninvasive MRI spectroscopy

Research by Stefan Blüml, Ph.D., and colleagues investigates the usage of successful vivo proton magnetic resonance spectroscopy (¹H-MRS) to place medulloblastoma molecular subgroups earlier surgery, a noninvasive alternate to surgical tumor sampling that could assistance enactment attraction readying astatine an earlier stage. The survey is published successful the diary Neuro-Oncology.